A method to codetect introduced genes and their products in gene therapy protocols

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Gene therapy requires methods to monitor introduced genes and their protein products in host tissues.
• Current methods like PCR and protein detection have limitations in sensitivity and information provided.

Purpose of the Study:

• To develop and validate a combined fluorescence in situ hybridization (FISH) and immunohistochemistry assay.
• To assess the distribution and expression of genes and proteins in gene therapy models.

Main Methods:

• Combined FISH and immunohistochemistry applied to animal models of gene therapy (pHSVlac vector in brain).
• Analysis of myoblast transplantation in a patient with Duchenne's muscular dystrophy.

Main Results:

• Localized vector DNA in both expressing and non-expressing cells, indicating cellular control over gene expression.
• Detected donor nuclei in muscle fibers of a Duchenne's muscular dystrophy patient, with some fused and producing dystrophin.
• Demonstrated higher sensitivity and more comprehensive data compared to PCR and protein detection.

Conclusions:

• The combined FISH and immunohistochemistry assay is a sensitive tool for monitoring gene transfer and expression.
• Cellular factors influence gene expression efficiency post-transfer.
• The method shows promise for evaluating gene therapy outcomes in genetic disorders.